Orange or citrus flavor [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2020-02-20 08:41 (428 d 01:46 ago) – Posting: # 21183
Views: 938

Hi Dr_Dan,

it is a tricky question. On whom is the burden of proof here?

I would perhaps try and argue that since the excipient is common, used for decades, generally allowed and since PRAC and CHMP and SWP and so forth did not in any way indicate the need for a review of safety/potential toxicity etc., the excipient should be considered ok.
At the end of the day the purpose of the regulatory mechanisms is to capture those things since they have access to much more info then you/we have. Their analysis is potentially much more sensitive than anything you can look into or speculate into.

Absence of evidence vs evidence of absence...

Pass or fail!

Complete thread:

 Admin contact
21,427 posts in 4,479 threads, 1,512 registered users;
online 16 (2 registered, 14 guests [including 3 identified bots]).
Forum time: Friday 10:27 UTC (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz